Overview
MSLE market data
Price History
MSLE price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.70 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.58 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $6.24 – $18.98 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $207.3 · P/B 3.18.
Company news
Satellos Bioscience Duchenne Drug Candidate's Interim Data Boosts ConfidenceBenzinga · Jul 8, 2026, 1:40 PM
Satellos Gets FDA Fast Track Status For Duchenne DrugBenzinga · Jun 29, 2026, 11:20 AM
Satellos Bioscience Announces Results of Annual Meeting of ShareholdersGlobenewswire Inc · Jun 17, 2026, 9:15 PM
Satellos to Participate in Upcoming Investor ConferencesGlobenewswire Inc · May 27, 2026, 11:15 AM
HC Wainwright & Co. Reiterates Buy on Satellos Bioscience, Maintains $11 Price TargetBenzinga · May 18, 2026, 5:55 PM
Earnings Scheduled For May 15, 2026Benzinga · May 15, 2026, 11:15 AM
Satellos Bioscience Q1 EPS $(0.53) Down From $(0.44) YoYBenzinga · May 15, 2026, 11:15 AM